| 000 | 01598 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512230909.0 | ||
| 264 | 0 | _c19840719 | |
| 008 | 198407s 0 0 eng d | ||
| 022 | _a0161-5505 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSisson, J C | |
| 245 | 0 | 0 |
_aRadiopharmaceutical treatment of malignant pheochromocytoma. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cFeb 1984 |
||
| 300 |
_a197-206 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a3-Iodobenzylguanidine |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xadministration & dosage |
| 650 | 0 | 4 |
_aIodobenzenes _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aPheochromocytoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aShapiro, B | |
| 700 | 1 | _aBeierwaltes, W H | |
| 700 | 1 | _aGlowniak, J V | |
| 700 | 1 | _aNakajo, M | |
| 700 | 1 | _aMangner, T J | |
| 700 | 1 | _aCarey, J E | |
| 700 | 1 | _aSwanson, D P | |
| 700 | 1 | _aCopp, J E | |
| 700 | 1 | _aSatterlee, W G | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 25 _gno. 2 _gp. 197-206 |
|
| 999 |
_c6726215 _d6726215 |
||